Is there any role for neoadjuvant therapy in urothelial Tis refractory to BCG therapy?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Seven Rivers Regional Medical Center
What about Pembrolizunab?
Medical Oncologist at University of Washington School of Medicine
Good question. Pembrolizumab is being tested as si...
Medical Oncologist at University of Washington School of Medicine
P.S: S1605 phase II trial is testing atezolizumab ...
Medical Oncologist at Norton Cancer Institute
Could you comment on this consideration now that p...
Medical Oncologist at University of Washington School of Medicine
Pembrolizumab is a very reasonable option and now ...
Sign in or Register to read more